IGMS: IGM Biosciences, Inc. Stock

by  •  • Comments Off on IGMS: IGM Biosciences, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 47.03
Enterprise Value ($M) 4.15
Book Value ($M) 78.95
Book Value / Share 2.32
Price / Book 0.60
NCAV ($M) 4.07
NCAV / Share 0.12
Price / NCAV 11.55

Profitability (mra)
Return on Invested Capital (ROIC) -1.76
Return on Assets (ROA) -0.52
Return on Equity (ROE) -1.08

Liquidity (mrq)
Quick Ratio 5.22
Current Ratio 5.22

Balance Sheet (mrq) ($M)
Current Assets 229.63
Assets 304.51
Liabilities 225.56
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-14 13G/A Price T Rowe Associates Inc /md/
11-12 13G/A Fmr Llc 2.42 -51.75
08-02 13G/A Invus Global Management, LLC 9.90
03-28 13D/A Baker Bros. Advisors Lp 12.40 10.71
2024-02-09 13G/A Artal International S.C.A. 9.40 26.55

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-11-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-08-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-05-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-03-07 10-K Form 10-K

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-02-24 51,458 182,996 28.12
2025-02-21 55,062 155,933 35.31
2025-02-20 75,605 174,109 43.42
2025-02-19 62,417 287,822 21.69

(click for more detail)

Similar Companies
IDXX – IDEXX Laboratories, Inc. IDYA – IDEAYA Biosciences, Inc.
IFRX – InflaRx N.V. IMUX – Immunic, Inc.
IMVT – Immunovant, Inc.


Financial data and stock pages provided by
Fintel.io